Important message

New website lounch

In April 2015 we launched our new website!


Event calendar

Today < 2017 > < November >
Mo Tu We Th Fr Sa Su
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30    


  • Janovský M., Kršiak M. (2011): Codeine did not increase analgesic efficacy of coxibs in contrast to that of paracetamol or ibuprofen: isobolographic analysis in mice. Neuroendocrinology Letters 32(2):164-169.
  • Janovský, M; Doležal, T; Procházková, M; Slíva, J; Kršiak, M (2010): Influence on analgesic activity and serum levels after meloxicam complexation with beta-cyclodextrin in mice and rats.

    Arzneimittel-Forschung-Drug Research, 60 (6): 320-323. 

  • Soukupová, M; Palazzo, E; De Chiaro, M; Gatta, L; Migliozzi, AL; Guida, F; Luongo, L; Giordano, C; Siniscalco, D; De Novellis, V; Marabese, I; Kršiak, M; Maione, S (2010): Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol.Neuroendocrinology Letters, 31 (4): 507-511.

  • Hess L., Votava M.,Schreiberová J., Málek J. (2009):  The effect of the novel alpha-2adrenoceptor agonist naphthylmedetomidine on pulse rate, arterial blood pressure and sedation in rabbits. Vet. Anaesth.Analg. 36 (2): 144-150.

  • Votava M., Hess L., Schreiberová J., Málek J. (2009): The effect of the novel partial alpha2-adrenoceptor agonist naphthylmedetomidine on  the basic cardiorespiratory parameters and behavior in rhesus monkeys. J. Med. Primatol. 38(4):241-6.

  • Soukupová M., Doležal T., Kršiak M. (2009): The synergistic interaction between rilmenidine and paracetamol in the writhing test in mice. Naunyn-Schmiedeberg’s Archives of Pharmacology 379(6):575-80.

  • Slíva J., Doležal T., Sýkora  D, Vosmanská  M., Kršiak M. (2009): Guaifenesin enhances the analgesic potency of ibuprofen, nimesulide and celecoxibe in mice Neuroendocrinology Letters 30 (3): 352-356.
  • Soukupová M., Doležal T., Kršiak M. (2009): The synergistic interaction between rilmenidine and ibuprofen in the writhing test in mice. Neuroendocrinology Letters 30 (2): 215-220.
  • Šustková-Fišerová M., Vávrová J.,  Kršiak M. (2009): Brain levels of GABA,  glutamate and  aspartate in sociable, aggressive and timid mice: an in vivo microdialysis study. Neuroendocrinology Letters 30 (1):79-84.
  • Procházková M., Zanvit P., Doležal T., Prokešová L., Kršiak M.:Increased gene expression and production of spinal cyclooxygenase 1 and 2 during experimental osteoarthritis pain [accepted in Physiological Research; to appear in 2009].
  • Votava M., Hess L., Kršiak M. (2008): Selective antiaggressive effect of alpha-2 adrenoceptor agonist naphtylmedetomidine in mice.  Aggressive Behaviour 34 (4):394-403.
  • Sliva J., Dolezal T., Prochazkova M., Votava M., Krsiak M. (2008):  Preemptive levetiracetam decreases postoperative pain in rats. Neuroendocrinology Letters 29 (6): 953-957.
  • Winblad B, Fioravanti M, Dolezal T, Logina I, Milanov IG, Popescub DC, Solomon A (2008):  Therapeutic use of Nicergoline. Clinical Drug Investigation 28: 533-552.
  • Bubeníková-Valesová V, Votava M, Horácek J, Pálenicek T (2007): The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by  MK-801.Neuropharmacology Mar;52(4):1071-8.
  • Palenicek T, Hlinak Z, Bubenikova-Valesova V, Votava M, Horacek J (2007): An analysis of spontaneous behavior following acute MDMA treatment in male and female rats. Neuroendocrinology Letters 28: 781-788.
  • Magage S, Lubanda JC, Susa Z, Bultas J, Karetova D, Dobrovolny R, Hrebicek M, Germain DP, Linhart A (2007): Natural history of the respiratory involvement in Anderson-Fabry disease. Journal of Inherited Metabolic Disease 30: 790-799.
  • Clarke JTR, West ML, Bultas J, Schiffmann R (2007): The pharmacology of multiple regimens of agalsidase alfa enzyme replacement therapy for Fabry disease. Genetics in Medicine 9: 504-509.
  • Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M, Finkel R, Packman S, Bichet DG, Warnock DG, Desnick RJ (2007): Agalsidase-beta therapy for advanced Fabry disease - A randomized trial. Annals of Internal Medicine 146: 77-86.
  • Merta M, Reiterova J, Ledvinova J, Poupetova H, Dobrovolny R, Rysava R, Maixnerova D, Bultas J, Moltan J, Slivkova J, Sobotova D, Smrzova J, Tesar V (2007): A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population. Nephrology Dialysis Transplantation 22: 179-186.
  • Kršiak M. (2006): Human evolution: humanistic selection and looking to the future. Neuroendocrinology Letters. 27 (5 Oct 12): 563-567. 
  • Procházková M., Doležal T., Kršiak M. (2006): Different patterns of spinal cyclooxygenase-1 and cyclooxygenase-2 mRNA expression in inflammatory and postoperative pain.Basic Clin Pharmacol Toxicol. 99(2):173-7.
  • Schauer E., Wronski R., Patočková J., Moessler H., Doppler E., Hutter-Paier B., Windisch M. (2006): Neuroprotection of Cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide therapeutic window. J Neural Transm. 113(7):855-68.
  • Votava M., Hess L., Slíva J., Kršiak M., Agová V. (2005): Dexmedetomidine suppresses prevailing behaviour in aggressive and sociable mice. Europ. J. Pharmacol 523(1-3):79-85.
  • Uhlířová L., Šustková-Fišerová M., Kršiak M. (2004): Behavioral effects of flumazenil in the social conflict test in mice. Psychopharmacology 171 (3): 259-269.
  • Patočková J., Marhol P.,Tůmová E., Kršiak M., Rokyta R., Štípek S., Crkovská J., Anděl M. (2003): Oxidative stress in the brain tissue of laboratory mice with acute post insulin hypoglycemia. Physiol. Res. 52(1):131-5.
  • Patočková J., Kršiak M.,Marhol P., Tůmová E. (2003):  Cerebrolysin inhibits lipid peroxidation induced by insulin hypoglycemia in the brain and heart of mice. Physiol. Res. 52: 455-460.
  • Doležal T., Kršiak M. (2002): Guaifenesin enhances the analgesic potency of paracetamol without affecting its behavioral activity. Naunyn-Schmiedeberg’s Archives of Pharmacology 366: 551-554.
  • Doležal T., Němeček K., Kršiak M. (2002): Trends in consumption of calcium channel blockers in the Czech republic during 1993-1999 and comparison with selected copuntries: drug utilization study. Europ. J. clin. Pharmacol. 58: 477-478.
  • Votava M., Kršiak M., Moravec V. (2002): Effects of alprazolam and fluoxetine on morphine sensitization in mice. Physiol. Res. 51: 417-423.
  • Doležal T., Kršiak M. (2002): Amplification of analgesic effect of ibuprofen by alprazolam in experimental model of pain. Physiol. Res. 51: (2) 179-184.
  • Spanagel, R.,  Siegmund, S.,  Cowen, M.,  Schroff, K. Ch.,  Schumann, G.,  Fišerová, M. (2002): The neuronal nitric oxide synthase gene is critically involved in neurobehavioral effects of alcohol.  The Journal of Neuroscience,  2002, roč. 22, (19), s. 8676-8683.